YaƱez, Elbert G.
HRN: 22-74-14 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/02/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/02/2022
08/09/2022
IVT
1.5g
Q6
Fracture Open 4th And 5th Digit Of R Foot
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamBone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes